News Focus
News Focus
icon url

DewDiligence

01/18/14 7:22 PM

#172937 RE: jbog #172882

China is not worth the hassle.

That’s not the right interpretation, IMO. As you just posted in #msg-96103430, Actavis is pulling back in multiple regions—not just China—which is consistent with the commentary in #msg-96043132.